Reactive oxygen species in metabolic and inflammatory signaling

SJ Forrester, DS Kikuchi, MS Hernandes, Q Xu… - Circulation …, 2018 - Am Heart Assoc
Reactive oxygen species (ROS) are well known for their role in mediating both physiological
and pathophysiological signal transduction. Enzymes and subcellular compartments that …

[HTML][HTML] Reperfusion injury and reactive oxygen species: The evolution of a concept

DN Granger, PR Kvietys - Redox biology, 2015 - Elsevier
Reperfusion injury, the paradoxical tissue response that is manifested by blood flow-
deprived and oxygen-starved organs following the restoration of blood flow and tissue …

[HTML][HTML] Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning

T Kalogeris, Y Bao, RJ Korthuis - Redox biology, 2014 - Elsevier
Reductions in the blood supply produce considerable injury if the duration of ischemia is
prolonged. Paradoxically, restoration of perfusion to ischemic organs can exacerbate tissue …

Functional role of mitochondrial reactive oxygen species in physiology

PR Angelova, AY Abramov - Free radical biology and medicine, 2016 - Elsevier
The major energy generator in the cell–mitochondria produce reactive oxygen species as a
by-product of a number of enzymatic reactions and the production of ATP. Emerging …

Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders

J Tong, G Rathitharan, JH Meyer, Y Furukawa, LC Ang… - Brain, 2017 - academic.oup.com
Abstract See Jellinger (doi: 10.1093/awx190) for a scientific commentary on this article. The
enzyme monoamine oxidases (B and A subtypes, encoded by MAOB and MAOA …

Natural products inhibitors of monoamine oxidases—Potential new drug leads for neuroprotection, neurological disorders, and neuroblastoma

ND Chaurasiya, F Leon, I Muhammad, BL Tekwani - Molecules, 2022 - mdpi.com
Monoamine oxidase inhibitors (MAOIs) are an important class of drugs prescribed for
treatment of depression and other neurological disorders. Evidence has suggested that …

Neuroprotective function of rasagiline and selegiline, inhibitors of type B monoamine oxidase, and role of monoamine oxidases in synucleinopathies

M Naoi, W Maruyama, M Shamoto-Nagai - International Journal of …, 2022 - mdpi.com
Synucleinopathies are a group of neurodegenerative disorders caused by the accumulation
of toxic species of α-synuclein. The common clinical features are chronic progressive …

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

DS Goldstein, IJ Kopin, Y Sharabi - Pharmacology & therapeutics, 2014 - Elsevier
Several neurodegenerative diseases involve loss of catecholamine neurons—Parkinson
disease is a prototypical example. Catecholamine neurons are rare in the nervous system …

90 years of monoamine oxidase: some progress and some confusion

KF Tipton - Journal of Neural Transmission, 2018 - Springer
It would not be practical to attempt to deal with all the advances that have informed our
understanding of the behavior and functions of this enzyme over the past 90 years. This …

Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression

M Naoi, P Riederer, W Maruyama - Journal of Neural Transmission, 2016 - Springer
Monoamine oxidase types A and B (MAO-A, MAO-B) regulate the levels of monoamine
neurotransmitters in the brain, and their dysfunction may be involved in the pathogenesis …